Copyright Reports & Markets. All rights reserved.

Global Clinical Trials Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Clinical Trials Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Phase I
      • 1.4.3 Phase II
      • 1.4.4 Phase III
      • 1.4.5 Phase IV
    • 1.5 Market by Application
      • 1.5.1 Global Clinical Trials Market Share by Application (2014-2025)
      • 1.5.2 Interventional
      • 1.5.3 Observational
      • 1.5.4 Expanded Access
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Clinical Trials Market Size
    • 2.2 Clinical Trials Growth Trends by Regions
      • 2.2.1 Clinical Trials Market Size by Regions (2014-2025)
      • 2.2.2 Clinical Trials Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Clinical Trials Market Size by Manufacturers
      • 3.1.1 Global Clinical Trials Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Clinical Trials Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Clinical Trials Market Concentration Ratio (CR5 and HHI)
    • 3.2 Clinical Trials Key Players Head office and Area Served
    • 3.3 Key Players Clinical Trials Product/Solution/Service
    • 3.4 Date of Enter into Clinical Trials Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Clinical Trials Market Size by Type (2014-2019)
    • 4.2 Global Clinical Trials Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Clinical Trials Market Size (2014-2019)
    • 5.2 Clinical Trials Key Players in United States
    • 5.3 United States Clinical Trials Market Size by Type
    • 5.4 United States Clinical Trials Market Size by Application

    6 Europe

    • 6.1 Europe Clinical Trials Market Size (2014-2019)
    • 6.2 Clinical Trials Key Players in Europe
    • 6.3 Europe Clinical Trials Market Size by Type
    • 6.4 Europe Clinical Trials Market Size by Application

    7 China

    • 7.1 China Clinical Trials Market Size (2014-2019)
    • 7.2 Clinical Trials Key Players in China
    • 7.3 China Clinical Trials Market Size by Type
    • 7.4 China Clinical Trials Market Size by Application

    8 Japan

    • 8.1 Japan Clinical Trials Market Size (2014-2019)
    • 8.2 Clinical Trials Key Players in Japan
    • 8.3 Japan Clinical Trials Market Size by Type
    • 8.4 Japan Clinical Trials Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Clinical Trials Market Size (2014-2019)
    • 9.2 Clinical Trials Key Players in Southeast Asia
    • 9.3 Southeast Asia Clinical Trials Market Size by Type
    • 9.4 Southeast Asia Clinical Trials Market Size by Application

    10 India

    • 10.1 India Clinical Trials Market Size (2014-2019)
    • 10.2 Clinical Trials Key Players in India
    • 10.3 India Clinical Trials Market Size by Type
    • 10.4 India Clinical Trials Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Clinical Trials Market Size (2014-2019)
    • 11.2 Clinical Trials Key Players in Central & South America
    • 11.3 Central & South America Clinical Trials Market Size by Type
    • 11.4 Central & South America Clinical Trials Market Size by Application

    12 International Players Profiles

    • 12.1 Quintiles IMS
      • 12.1.1 Quintiles IMS Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Clinical Trials Introduction
      • 12.1.4 Quintiles IMS Revenue in Clinical Trials Business (2014-2019)
      • 12.1.5 Quintiles IMS Recent Development
    • 12.2 Paraxel International Corporation
      • 12.2.1 Paraxel International Corporation Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Clinical Trials Introduction
      • 12.2.4 Paraxel International Corporation Revenue in Clinical Trials Business (2014-2019)
      • 12.2.5 Paraxel International Corporation Recent Development
    • 12.3 Charles River Laboratories
      • 12.3.1 Charles River Laboratories Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Clinical Trials Introduction
      • 12.3.4 Charles River Laboratories Revenue in Clinical Trials Business (2014-2019)
      • 12.3.5 Charles River Laboratories Recent Development
    • 12.4 ICON plc
      • 12.4.1 ICON plc Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Clinical Trials Introduction
      • 12.4.4 ICON plc Revenue in Clinical Trials Business (2014-2019)
      • 12.4.5 ICON plc Recent Development
    • 12.5 SGS SA
      • 12.5.1 SGS SA Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Clinical Trials Introduction
      • 12.5.4 SGS SA Revenue in Clinical Trials Business (2014-2019)
      • 12.5.5 SGS SA Recent Development
    • 12.6 Pharmaceutical Product Development, LLC
      • 12.6.1 Pharmaceutical Product Development, LLC Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Clinical Trials Introduction
      • 12.6.4 Pharmaceutical Product Development, LLC Revenue in Clinical Trials Business (2014-2019)
      • 12.6.5 Pharmaceutical Product Development, LLC Recent Development
    • 12.7 Wuxi AppTec Inc.
      • 12.7.1 Wuxi AppTec Inc. Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Clinical Trials Introduction
      • 12.7.4 Wuxi AppTec Inc. Revenue in Clinical Trials Business (2014-2019)
      • 12.7.5 Wuxi AppTec Inc. Recent Development
    • 12.8 PRA Health Sciences
      • 12.8.1 PRA Health Sciences Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Clinical Trials Introduction
      • 12.8.4 PRA Health Sciences Revenue in Clinical Trials Business (2014-2019)
      • 12.8.5 PRA Health Sciences Recent Development
    • 12.9 Chiltern International Ltd.
      • 12.9.1 Chiltern International Ltd. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Clinical Trials Introduction
      • 12.9.4 Chiltern International Ltd. Revenue in Clinical Trials Business (2014-2019)
      • 12.9.5 Chiltern International Ltd. Recent Development
    • 12.10 INC Research
      • 12.10.1 INC Research Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Clinical Trials Introduction
      • 12.10.4 INC Research Revenue in Clinical Trials Business (2014-2019)
      • 12.10.5 INC Research Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Clinical Trials market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Clinical Trials status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Clinical Trials development in United States, Europe and China.

      The key players covered in this study
      Quintiles IMS
      Paraxel International Corporation
      Charles River Laboratories
      ICON plc
      SGS SA
      Pharmaceutical Product Development, LLC
      Wuxi AppTec Inc.
      PRA Health Sciences
      Chiltern International Ltd.
      INC Research

      Market segment by Type, the product can be split into
      Phase I
      Phase II
      Phase III
      Phase IV

      Market segment by Application, split into
      Interventional
      Observational
      Expanded Access

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Clinical Trials status, future forecast, growth opportunity, key market and key players.
      To present the Clinical Trials development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Clinical Trials are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now